nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Arthralgia—Cladribine—multiple sclerosis	0.00401	0.00409	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00398	0.00406	CcSEcCtD
Gallamine Triethiodide—Confusional state—Cladribine—multiple sclerosis	0.00387	0.00395	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Cladribine—multiple sclerosis	0.00376	0.00384	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Cladribine—multiple sclerosis	0.00375	0.00383	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Cladribine—multiple sclerosis	0.00373	0.00381	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00357	0.00364	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Mitoxantrone—multiple sclerosis	0.00356	0.00364	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00355	0.00363	CcSEcCtD
Gallamine Triethiodide—Anaemia—Azathioprine—multiple sclerosis	0.00354	0.00361	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.0035	0.00357	CcSEcCtD
Gallamine Triethiodide—Malaise—Azathioprine—multiple sclerosis	0.00345	0.00352	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Cladribine—multiple sclerosis	0.00345	0.00352	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Azathioprine—multiple sclerosis	0.00343	0.0035	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00332	0.00338	CcSEcCtD
Gallamine Triethiodide—Fatigue—Cladribine—multiple sclerosis	0.00331	0.00338	CcSEcCtD
Gallamine Triethiodide—Pain—Cladribine—multiple sclerosis	0.00328	0.00335	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Azathioprine—multiple sclerosis	0.00326	0.00332	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00324	0.0033	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Methotrexate—multiple sclerosis	0.00319	0.00325	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Cladribine—multiple sclerosis	0.00317	0.00323	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.00306	0.00312	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00306	0.00312	CcSEcCtD
Gallamine Triethiodide—Urticaria—Cladribine—multiple sclerosis	0.00305	0.00311	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Cladribine—multiple sclerosis	0.00304	0.0031	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Cladribine—multiple sclerosis	0.00304	0.0031	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Azathioprine—multiple sclerosis	0.00303	0.0031	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00303	0.00309	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Methotrexate—multiple sclerosis	0.003	0.00306	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisolone—multiple sclerosis	0.00293	0.00299	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisolone—multiple sclerosis	0.00292	0.00297	CcSEcCtD
Gallamine Triethiodide—Anaemia—Mitoxantrone—multiple sclerosis	0.00286	0.00292	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00285	0.0029	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cladribine—multiple sclerosis	0.00283	0.00289	CcSEcCtD
Gallamine Triethiodide—Malaise—Mitoxantrone—multiple sclerosis	0.00279	0.00285	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Mitoxantrone—multiple sclerosis	0.00277	0.00283	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cladribine—multiple sclerosis	0.00276	0.00281	CcSEcCtD
Gallamine Triethiodide—Pruritus—Cladribine—multiple sclerosis	0.00272	0.00277	CcSEcCtD
Gallamine Triethiodide—Cough—Mitoxantrone—multiple sclerosis	0.0027	0.00275	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.0027	0.00275	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Triamcinolone—multiple sclerosis	0.00269	0.00275	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00269	0.00274	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Triamcinolone—multiple sclerosis	0.00269	0.00274	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Methylprednisolone—multiple sclerosis	0.00268	0.00274	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Triamcinolone—multiple sclerosis	0.00268	0.00274	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00267	0.00273	CcSEcCtD
Gallamine Triethiodide—Chest pain—Mitoxantrone—multiple sclerosis	0.00263	0.00269	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Mitoxantrone—multiple sclerosis	0.00263	0.00269	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cladribine—multiple sclerosis	0.00263	0.00268	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00257	0.00263	CcSEcCtD
Gallamine Triethiodide—Confusional state—Mitoxantrone—multiple sclerosis	0.00255	0.0026	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methylprednisolone—multiple sclerosis	0.0025	0.00255	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00248	0.00253	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00247	0.00252	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Azathioprine—multiple sclerosis	0.00247	0.00252	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Azathioprine—multiple sclerosis	0.00247	0.00252	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Mitoxantrone—multiple sclerosis	0.00246	0.00251	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Mitoxantrone—multiple sclerosis	0.00245	0.0025	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Dexamethasone—multiple sclerosis	0.00244	0.00249	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Betamethasone—multiple sclerosis	0.00244	0.00249	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cladribine—multiple sclerosis	0.00244	0.00249	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Dexamethasone—multiple sclerosis	0.00243	0.00248	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Betamethasone—multiple sclerosis	0.00243	0.00248	CcSEcCtD
Gallamine Triethiodide—Rash—Cladribine—multiple sclerosis	0.00242	0.00247	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cladribine—multiple sclerosis	0.00242	0.00247	CcSEcCtD
Gallamine Triethiodide—Headache—Cladribine—multiple sclerosis	0.00241	0.00246	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisolone—multiple sclerosis	0.00232	0.00237	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Azathioprine—multiple sclerosis	0.0023	0.00235	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.0023	0.00235	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisolone—multiple sclerosis	0.00229	0.00234	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Triamcinolone—multiple sclerosis	0.00229	0.00233	CcSEcCtD
Gallamine Triethiodide—Nausea—Cladribine—multiple sclerosis	0.00228	0.00233	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Dexamethasone—multiple sclerosis	0.00227	0.00232	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Betamethasone—multiple sclerosis	0.00227	0.00232	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00227	0.00231	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Methotrexate—multiple sclerosis	0.00219	0.00223	CcSEcCtD
Gallamine Triethiodide—Fatigue—Mitoxantrone—multiple sclerosis	0.00218	0.00222	CcSEcCtD
Gallamine Triethiodide—Pain—Mitoxantrone—multiple sclerosis	0.00216	0.0022	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Azathioprine—multiple sclerosis	0.00214	0.00218	CcSEcCtD
Gallamine Triethiodide—Angioedema—Triamcinolone—multiple sclerosis	0.00213	0.00218	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisone—multiple sclerosis	0.00213	0.00217	CcSEcCtD
Gallamine Triethiodide—Angioedema—Methylprednisolone—multiple sclerosis	0.00213	0.00217	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00212	0.00216	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisone—multiple sclerosis	0.00212	0.00216	CcSEcCtD
Gallamine Triethiodide—Malaise—Triamcinolone—multiple sclerosis	0.0021	0.00215	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Methotrexate—multiple sclerosis	0.0021	0.00214	CcSEcCtD
Gallamine Triethiodide—Malaise—Methylprednisolone—multiple sclerosis	0.0021	0.00214	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00208	0.00212	CcSEcCtD
Gallamine Triethiodide—Cough—Triamcinolone—multiple sclerosis	0.00204	0.00208	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Prednisolone—multiple sclerosis	0.00202	0.00206	CcSEcCtD
Gallamine Triethiodide—Urticaria—Mitoxantrone—multiple sclerosis	0.00201	0.00205	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.002	0.00204	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.002	0.00204	CcSEcCtD
Gallamine Triethiodide—Vomiting—Azathioprine—multiple sclerosis	0.00199	0.00203	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methylprednisolone—multiple sclerosis	0.00198	0.00202	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Prednisone—multiple sclerosis	0.00198	0.00202	CcSEcCtD
Gallamine Triethiodide—Rash—Azathioprine—multiple sclerosis	0.00197	0.00201	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00197	0.00201	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Azathioprine—multiple sclerosis	0.00197	0.00201	CcSEcCtD
Gallamine Triethiodide—Headache—Azathioprine—multiple sclerosis	0.00196	0.002	CcSEcCtD
Gallamine Triethiodide—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00195	0.0973	CbGpPWpGaD
Gallamine Triethiodide—Angioedema—Betamethasone—multiple sclerosis	0.00193	0.00197	CcSEcCtD
Gallamine Triethiodide—Angioedema—Dexamethasone—multiple sclerosis	0.00193	0.00197	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methylprednisolone—multiple sclerosis	0.00192	0.00196	CcSEcCtD
Gallamine Triethiodide—Malaise—Dexamethasone—multiple sclerosis	0.00191	0.00195	CcSEcCtD
Gallamine Triethiodide—Malaise—Betamethasone—multiple sclerosis	0.00191	0.00195	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00186	0.0019	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisolone—multiple sclerosis	0.00186	0.0019	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Triamcinolone—multiple sclerosis	0.00186	0.0019	CcSEcCtD
Gallamine Triethiodide—Nausea—Azathioprine—multiple sclerosis	0.00185	0.00189	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Methylprednisolone—multiple sclerosis	0.00185	0.00189	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methylprednisolone—multiple sclerosis	0.00185	0.00188	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mitoxantrone—multiple sclerosis	0.00181	0.00185	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—multiple sclerosis	0.00178	0.00182	CcSEcCtD
Gallamine Triethiodide—Pain—Prednisolone—multiple sclerosis	0.00177	0.00181	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—multiple sclerosis	0.00177	0.00181	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00174	0.00177	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00173	0.00177	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00173	0.00176	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00171	0.00175	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisolone—multiple sclerosis	0.00171	0.00174	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00171	0.00174	CcSEcCtD
Gallamine Triethiodide—Anaemia—Prednisone—multiple sclerosis	0.0017	0.00174	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00169	0.00173	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00169	0.00173	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Dexamethasone—multiple sclerosis	0.00169	0.00172	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Betamethasone—multiple sclerosis	0.00169	0.00172	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisone—multiple sclerosis	0.00169	0.00172	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisone—multiple sclerosis	0.00166	0.0017	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—multiple sclerosis	0.00165	0.00169	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisolone—multiple sclerosis	0.00165	0.00168	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—multiple sclerosis	0.00164	0.00168	CcSEcCtD
Gallamine Triethiodide—Fatigue—Triamcinolone—multiple sclerosis	0.00164	0.00168	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methylprednisolone—multiple sclerosis	0.00164	0.00167	CcSEcCtD
Gallamine Triethiodide—Pain—Triamcinolone—multiple sclerosis	0.00163	0.00166	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mitoxantrone—multiple sclerosis	0.00161	0.00164	CcSEcCtD
Gallamine Triethiodide—Rash—Mitoxantrone—multiple sclerosis	0.00159	0.00162	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mitoxantrone—multiple sclerosis	0.00159	0.00162	CcSEcCtD
Gallamine Triethiodide—Headache—Mitoxantrone—multiple sclerosis	0.00158	0.00161	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00157	0.00161	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Prednisone—multiple sclerosis	0.00157	0.0016	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00157	0.0016	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00157	0.0016	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00156	0.00159	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Dexamethasone—multiple sclerosis	0.00155	0.00158	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Betamethasone—multiple sclerosis	0.00155	0.00158	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisolone—multiple sclerosis	0.00153	0.00156	CcSEcCtD
Gallamine Triethiodide—Urticaria—Triamcinolone—multiple sclerosis	0.00151	0.00154	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methylprednisolone—multiple sclerosis	0.00151	0.00154	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—multiple sclerosis	0.00151	0.00154	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Triamcinolone—multiple sclerosis	0.00151	0.00154	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.0015	0.00153	CcSEcCtD
Gallamine Triethiodide—Nausea—Mitoxantrone—multiple sclerosis	0.0015	0.00153	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00149	0.00152	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00149	0.00152	CcSEcCtD
Gallamine Triethiodide—Fatigue—Betamethasone—multiple sclerosis	0.00149	0.00152	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dexamethasone—multiple sclerosis	0.00149	0.00152	CcSEcCtD
Gallamine Triethiodide—Pain—Dexamethasone—multiple sclerosis	0.00148	0.00151	CcSEcCtD
Gallamine Triethiodide—Pain—Betamethasone—multiple sclerosis	0.00148	0.00151	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Prednisone—multiple sclerosis	0.00147	0.0015	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Prednisone—multiple sclerosis	0.00146	0.00149	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—multiple sclerosis	0.00142	0.00145	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Betamethasone—multiple sclerosis	0.00142	0.00145	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00142	0.00145	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.0014	0.00143	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.0014	0.00143	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—multiple sclerosis	0.00139	0.00142	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—multiple sclerosis	0.00138	0.00141	CcSEcCtD
Gallamine Triethiodide—Urticaria—Betamethasone—multiple sclerosis	0.00137	0.0014	CcSEcCtD
Gallamine Triethiodide—Urticaria—Dexamethasone—multiple sclerosis	0.00137	0.0014	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00137	0.0014	CcSEcCtD
Gallamine Triethiodide—Asthenia—Triamcinolone—multiple sclerosis	0.00137	0.00139	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dexamethasone—multiple sclerosis	0.00137	0.00139	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Betamethasone—multiple sclerosis	0.00137	0.00139	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Betamethasone—multiple sclerosis	0.00137	0.00139	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dexamethasone—multiple sclerosis	0.00137	0.00139	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methylprednisolone—multiple sclerosis	0.00136	0.00139	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisone—multiple sclerosis	0.00135	0.00138	CcSEcCtD
Gallamine Triethiodide—Pruritus—Triamcinolone—multiple sclerosis	0.00135	0.00138	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—multiple sclerosis	0.00134	0.00137	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methylprednisolone—multiple sclerosis	0.00134	0.00137	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—multiple sclerosis	0.00131	0.00134	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—multiple sclerosis	0.00131	0.00134	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisolone—multiple sclerosis	0.00131	0.00133	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisolone—multiple sclerosis	0.0013	0.00133	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0013	0.00133	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0013	0.00133	CcSEcCtD
Gallamine Triethiodide—Fatigue—Prednisone—multiple sclerosis	0.0013	0.00132	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisolone—multiple sclerosis	0.0013	0.00132	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—multiple sclerosis	0.00127	0.00129	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisone—multiple sclerosis	0.00124	0.00127	CcSEcCtD
Gallamine Triethiodide—Asthenia—Betamethasone—multiple sclerosis	0.00124	0.00127	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dexamethasone—multiple sclerosis	0.00124	0.00127	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00123	0.00126	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisolone—multiple sclerosis	0.00123	0.00126	CcSEcCtD
Gallamine Triethiodide—Pruritus—Dexamethasone—multiple sclerosis	0.00122	0.00125	CcSEcCtD
Gallamine Triethiodide—Pruritus—Betamethasone—multiple sclerosis	0.00122	0.00125	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—multiple sclerosis	0.00122	0.00125	CcSEcCtD
Gallamine Triethiodide—Vomiting—Triamcinolone—multiple sclerosis	0.00121	0.00124	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methylprednisolone—multiple sclerosis	0.00121	0.00123	CcSEcCtD
Gallamine Triethiodide—Rash—Triamcinolone—multiple sclerosis	0.0012	0.00123	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Triamcinolone—multiple sclerosis	0.0012	0.00122	CcSEcCtD
Gallamine Triethiodide—Rash—Methylprednisolone—multiple sclerosis	0.0012	0.00122	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methylprednisolone—multiple sclerosis	0.0012	0.00122	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisone—multiple sclerosis	0.0012	0.00122	CcSEcCtD
Gallamine Triethiodide—Headache—Triamcinolone—multiple sclerosis	0.00119	0.00122	CcSEcCtD
Gallamine Triethiodide—Headache—Methylprednisolone—multiple sclerosis	0.00119	0.00121	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Prednisone—multiple sclerosis	0.00119	0.00121	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Prednisone—multiple sclerosis	0.00119	0.00121	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dexamethasone—multiple sclerosis	0.00118	0.00121	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Betamethasone—multiple sclerosis	0.00118	0.00121	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00115	0.00117	CcSEcCtD
Gallamine Triethiodide—Nausea—Triamcinolone—multiple sclerosis	0.00113	0.00115	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—multiple sclerosis	0.00113	0.00115	CcSEcCtD
Gallamine Triethiodide—Nausea—Methylprednisolone—multiple sclerosis	0.00113	0.00115	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisone—multiple sclerosis	0.00111	0.00113	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dexamethasone—multiple sclerosis	0.0011	0.00112	CcSEcCtD
Gallamine Triethiodide—Vomiting—Betamethasone—multiple sclerosis	0.0011	0.00112	CcSEcCtD
Gallamine Triethiodide—Rash—Dexamethasone—multiple sclerosis	0.00109	0.00111	CcSEcCtD
Gallamine Triethiodide—Rash—Betamethasone—multiple sclerosis	0.00109	0.00111	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Dexamethasone—multiple sclerosis	0.00109	0.00111	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Betamethasone—multiple sclerosis	0.00109	0.00111	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00109	0.00111	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—multiple sclerosis	0.00108	0.00111	CcSEcCtD
Gallamine Triethiodide—Headache—Betamethasone—multiple sclerosis	0.00108	0.0011	CcSEcCtD
Gallamine Triethiodide—Headache—Dexamethasone—multiple sclerosis	0.00108	0.0011	CcSEcCtD
Gallamine Triethiodide—Asthenia—Prednisone—multiple sclerosis	0.00108	0.0011	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—multiple sclerosis	0.00108	0.0011	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—multiple sclerosis	0.00107	0.0532	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Prednisone—multiple sclerosis	0.00106	0.00109	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—multiple sclerosis	0.00104	0.00106	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Prednisone—multiple sclerosis	0.00103	0.00105	CcSEcCtD
Gallamine Triethiodide—Nausea—Betamethasone—multiple sclerosis	0.00103	0.00105	CcSEcCtD
Gallamine Triethiodide—Nausea—Dexamethasone—multiple sclerosis	0.00103	0.00105	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—multiple sclerosis	0.000999	0.00102	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—multiple sclerosis	0.000994	0.00101	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—multiple sclerosis	0.000994	0.00101	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis of PC—BCHE—multiple sclerosis	0.000976	0.0487	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Prednisone—multiple sclerosis	0.000957	0.000977	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisone—multiple sclerosis	0.000949	0.000968	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisone—multiple sclerosis	0.000948	0.000967	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisone—multiple sclerosis	0.000943	0.000962	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000927	0.000946	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.000906	0.0452	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Methotrexate—multiple sclerosis	0.000902	0.000921	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisone—multiple sclerosis	0.000894	0.000912	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—multiple sclerosis	0.00089	0.000908	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—multiple sclerosis	0.000861	0.000878	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methotrexate—multiple sclerosis	0.0008	0.000816	CcSEcCtD
Gallamine Triethiodide—Rash—Methotrexate—multiple sclerosis	0.000793	0.000809	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—multiple sclerosis	0.000792	0.000809	CcSEcCtD
Gallamine Triethiodide—Headache—Methotrexate—multiple sclerosis	0.000788	0.000804	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—multiple sclerosis	0.000747	0.000762	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—KCNA3—multiple sclerosis	0.000656	0.0327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000579	0.0289	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.000552	0.0275	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—SELE—multiple sclerosis	0.00052	0.026	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000419	0.0209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—S1PR1—multiple sclerosis	0.000409	0.0204	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—KCNA3—multiple sclerosis	0.000406	0.0202	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000294	0.0147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—BCHE—multiple sclerosis	0.000286	0.0143	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000268	0.0134	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—IL1B—multiple sclerosis	0.000247	0.0123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00024	0.012	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00024	0.012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000235	0.0117	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—BCHE—multiple sclerosis	0.0002	0.00997	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CXCR3—multiple sclerosis	0.0002	0.00997	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000192	0.00955	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—BCHE—multiple sclerosis	0.000184	0.00918	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000182	0.00909	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CNR1—multiple sclerosis	0.000179	0.00895	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—multiple sclerosis	0.000179	0.00893	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.00017	0.00846	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000163	0.00812	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000152	0.0076	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000152	0.00759	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000149	0.00741	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000148	0.00737	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000148	0.00737	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000147	0.00733	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000143	0.00715	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000141	0.00704	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000141	0.00704	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000131	0.00654	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CCR5—multiple sclerosis	0.000125	0.00625	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000123	0.00612	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000118	0.00589	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000116	0.00578	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000115	0.00575	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—BCHE—multiple sclerosis	0.000114	0.00568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000112	0.0056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000112	0.0056	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000104	0.00519	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000101	0.00504	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	9.43e-05	0.0047	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCR3—multiple sclerosis	9.35e-05	0.00467	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GPR65—multiple sclerosis	9.35e-05	0.00466	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SRM—multiple sclerosis	9.34e-05	0.00466	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.33e-05	0.00466	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCR2—multiple sclerosis	9.1e-05	0.00454	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	9e-05	0.00449	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	8.99e-05	0.00448	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—multiple sclerosis	8.86e-05	0.00442	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	8.68e-05	0.00433	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL13—multiple sclerosis	8.55e-05	0.00426	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR1—multiple sclerosis	8.55e-05	0.00426	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	8.45e-05	0.00421	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	8.42e-05	0.0042	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR1—multiple sclerosis	8.4e-05	0.00419	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	8e-05	0.00399	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	7.79e-05	0.00389	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.7e-05	0.00384	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	7.6e-05	0.00379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL10—multiple sclerosis	7.56e-05	0.00377	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.44e-05	0.00371	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.24e-05	0.00361	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.02e-05	0.0035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.68e-05	0.00333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP24A1—multiple sclerosis	6.58e-05	0.00328	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP27B1—multiple sclerosis	6.58e-05	0.00328	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—S1PR1—multiple sclerosis	6.55e-05	0.00327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCL5—multiple sclerosis	6.51e-05	0.00325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.43e-05	0.00321	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL3—multiple sclerosis	6.09e-05	0.00304	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPC5—multiple sclerosis	6.02e-05	0.003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	6.01e-05	0.003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	5.95e-05	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	5.86e-05	0.00293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	5.86e-05	0.00292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	5.66e-05	0.00283	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	5.57e-05	0.00278	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	5.56e-05	0.00277	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	5.51e-05	0.00275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	5.44e-05	0.00271	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—MAPK1—multiple sclerosis	5.38e-05	0.00268	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	5.28e-05	0.00264	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.18e-05	0.00258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	5.08e-05	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	5.06e-05	0.00252	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—RRM1—multiple sclerosis	4.99e-05	0.00249	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	4.83e-05	0.00241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	4.83e-05	0.00241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	4.8e-05	0.00239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.72e-05	0.00235	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.66e-05	0.00233	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	4.64e-05	0.00231	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.6e-05	0.0023	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.59e-05	0.00229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	4.58e-05	0.00229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	4.58e-05	0.00228	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.5e-05	0.00225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	4.39e-05	0.00219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	4.39e-05	0.00219	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.34e-05	0.00216	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.29e-05	0.00214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	4.02e-05	0.00201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	3.94e-05	0.00197	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.87e-05	0.00193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	3.73e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.64e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.57e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	3.55e-05	0.00177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	3.52e-05	0.00175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.43e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	3.42e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MAPK1—multiple sclerosis	3.33e-05	0.00166	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.33e-05	0.00166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	3.31e-05	0.00165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.2e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	3.13e-05	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	3.11e-05	0.00155	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.03e-05	0.00151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	3.01e-05	0.0015	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	2.99e-05	0.00149	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	2.91e-05	0.00145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	2.87e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—POMC—multiple sclerosis	2.87e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BCHE—multiple sclerosis	2.87e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	2.83e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	2.83e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	2.81e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	2.77e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.76e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	2.72e-05	0.00135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	2.61e-05	0.0013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	2.35e-05	0.00117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	2.23e-05	0.00111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	2.02e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.01e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.98e-05	0.000986	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.85e-05	0.000921	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.82e-05	0.000909	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.8e-05	0.000896	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.78e-05	0.000887	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.75e-05	0.000873	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—multiple sclerosis	1.72e-05	0.00086	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.72e-05	0.000856	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.7e-05	0.000848	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.67e-05	0.000833	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.57e-05	0.000782	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.54e-05	0.000769	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—POMC—multiple sclerosis	1.48e-05	0.000739	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.42e-05	0.00071	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1.39e-05	0.000695	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1.39e-05	0.000692	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—multiple sclerosis	1.35e-05	0.000673	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.27e-05	0.000631	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.21e-05	0.000605	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.19e-05	0.000596	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.16e-05	0.000578	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.11e-05	0.000552	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.08e-05	0.000537	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.06e-05	0.000529	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.05e-05	0.000525	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—multiple sclerosis	9.79e-06	0.000488	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD80—multiple sclerosis	8.85e-06	0.000442	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—POMC—multiple sclerosis	8.41e-06	0.00042	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	8.23e-06	0.000411	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	8.05e-06	0.000402	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	7.47e-06	0.000373	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—multiple sclerosis	6.22e-06	0.00031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	6.19e-06	0.000309	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	5.89e-06	0.000294	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	5.23e-06	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.86e-06	0.000243	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.85e-06	0.000242	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.76e-06	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.66e-06	0.000182	CbGpPWpGaD
